Miguel Romero

ORCID: 0000-0003-4270-3057
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Coronary Interventions and Diagnostics
  • Cardiac Valve Diseases and Treatments
  • Cardiac Imaging and Diagnostics
  • Acute Myocardial Infarction Research
  • Congenital Heart Disease Studies
  • Cardiac Structural Anomalies and Repair
  • Aortic Disease and Treatment Approaches
  • Infective Endocarditis Diagnosis and Management
  • Cardiac pacing and defibrillation studies
  • Coronary Artery Anomalies
  • Cardiovascular and Diving-Related Complications
  • Cerebrovascular and Carotid Artery Diseases
  • Cardiac Arrhythmias and Treatments
  • Mesenchymal stem cell research
  • Social Sciences and Policies
  • Cardiovascular Function and Risk Factors
  • Tissue Engineering and Regenerative Medicine
  • Vascular Procedures and Complications
  • Peripheral Artery Disease Management
  • Aortic aneurysm repair treatments
  • Mechanical Circulatory Support Devices
  • Cardiac and Coronary Surgery Techniques
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Cardiac Fibrosis and Remodeling
  • Atrial Fibrillation Management and Outcomes

Hospital Universitario Reina Sofía
2015-2024

Instituto Maimónides de Investigación Biomédica de Córdoba
2015-2024

Centro de Investigación Biomédica en Red
2024

Centro de Investigación en Red en Enfermedades Cardiovasculares
2024

University of Córdoba
2015-2024

Benemérita Universidad Autónoma de Puebla
2024

Instituto del Mar del Peru
2009-2020

Institute for Research in Biomedicine
2016-2020

Hospital de Santa Maria
2008

Universidad de Las Palmas de Gran Canaria
1991-2002

Patients with diabetes mellitus are at high risk of adverse events after percutaneous revascularization, no differences in outcomes between most contemporary drug-eluting stents. The Cre8 EVO stent releases a formulation sirolimus an amphiphilic carrier from laser-dug wells, and has shown clinical benefits diabetes. We aimed to compare stents Resolute Onyx (a polymer-based zotarolimus-eluting stent) patients

10.1093/eurheartj/ehab790 article EN cc-by-nc European Heart Journal 2021-11-04

Background: Transcatheter mitral valve repair (TMVR) is an effective therapy for high-risk patients with severe regurgitation (MR) but heart failure (HF) readmissions and death remain substantial on mid-term follow-up. Recently, right ventricular (RV) to pulmonary arterial (PA) coupling has emerged as a relevant prognostic predictor in HF. In this study, we aimed assess the value of tricuspid annular plane systolic excursion (TAPSE) PA pressure (PASP) ratio non-invasive measure RV-to-PA...

10.3390/jcm10051006 article EN Journal of Clinical Medicine 2021-03-02

Abstract Several observational studies have shown a better late outcome in patients with coronary bifurcation lesions treated stents whom the side branch was not stented. Balloon dilation and provisional stenting for seem an attractive strategy to manage these challenging types of lesions. This study evaluated results three‐step phase stent treatment bifurcated We 126 patients, 58 ± 11 years old, major stenosis. The therapeutic procedure undertaken following three phases; progression through...

10.1002/ccd.10057 article EN Catheterization and Cardiovascular Interventions 2001-12-20

Introduction There is current controversy surrounding the benefits of percutaneous coronary intervention (PCI) chronic total occlusions (CTO). We aimed to evaluate impact complete revascularization on major adverse cardiovascular events (MACE) in patients with CTO. Methods A retrospective observational study was conducted consecutive referred for invasive angiography at a single center between January 2018 and December 2019 least The were divided into two groups according result procedure:...

10.3389/fcvm.2024.1443258 article EN cc-by Frontiers in Cardiovascular Medicine 2024-07-23

Abstract Objectives To compare the efficacy of sirolimus‐ and everolimus‐eluting stents in patients with bifurcation lesions treated provisional side‐branch stenting. Background The has been poorly tested. Methods Patients all types Medina were randomly assigned to treatment either a ( n = 145) or stent 148). We included main vessel diameter over 2.5 mm side branches 2.25 mm. diffuse stenosis excluded. Results There no significant differences between from sirolimus everolimus groups terms...

10.1002/ccd.24281 article EN Catheterization and Cardiovascular Interventions 2012-04-17

Percutaneous device occlusion of secundum atrial septal defects (ASDs) is becoming an accepted alternative to surgical closure. This method allows us evaluate patients with complex conditions for treatment. From a total 70 ASD evaluated percutaneous closure, we selected analysis 28 who had conditions. The mean age was 36+/-23 yr (range, 4-72). Six heart failure, and these six, three fibrillation. At cardiac catheterization, the pulmonary pressure 47+/-24 mm Hg, QP/QS 1.7+/-0.4; two...

10.1002/1522-726x(200009)51:1<33::aid-ccd9>3.0.co;2-5 article EN Catheterization and Cardiovascular Interventions 2000-01-01
Coming Soon ...